A dominant function of LynB kinase in preventing autoimmunity

Ben F Brian, Monica L Sauer, Joseph T Greene, S Erandika Senevirathne, Anders J Lindstedt, Olivia L Funk, Brian L Ruis, Luis A Ramirez, Jennifer L Auger, Whitney L Swanson, Myra G Nunez, Branden S Moriarity, Clifford A Lowell, Bryce A Binstadt, Tanya S Freedman

Research output: Contribution to journalArticlepeer-review


Here, we report that the LynB splice variant of the Src-family kinase Lyn exerts a dominant immunosuppressive function in vivo, whereas the LynA isoform is uniquely required to restrain autoimmunity in female mice. We used CRISPR-Cas9 gene editing to constrain lyn splicing and expression, generating single-isoform LynA knockout (LynA KO) or LynB KO mice. Autoimmune disease in total Lyn KO mice is characterized by production of antinuclear antibodies, glomerulonephritis, impaired B cell development, and overabundance of activated B cells and proinflammatory myeloid cells. Expression of LynA or LynB alone uncoupled the developmental phenotype from the autoimmune disease: B cell transitional populations were restored, but myeloid cells and differentiated B cells were dysregulated. These changes were isoform-specific, sexually dimorphic, and distinct from the complete Lyn KO. Despite the apparent differences in disease etiology and penetrance, loss of either LynA or LynB had the potential to induce severe autoimmune disease with parallels to human systemic lupus erythematosus (SLE).

Original languageEnglish (US)
Article numberabj5227
Pages (from-to)eabj5227
JournalScience Advances
Issue number16
StatePublished - Apr 22 2022

Bibliographical note

Publisher Copyright:
© 2022 The Authors.

PubMed: MeSH publication types

  • Journal Article


Dive into the research topics of 'A dominant function of LynB kinase in preventing autoimmunity'. Together they form a unique fingerprint.

Cite this